Elective hysterectomy. Benefits, risks, and costs.

Area of Science:

• Gynecologic Oncology
• Reproductive Medicine
• Health Economics

Background:

• Hysterectomy is a common surgical procedure for various gynecological conditions.
• The long-term impacts of hysterectomy on life expectancy and quality of life require comprehensive evaluation.
• Decision analysis models can integrate complex data to assess health outcomes.

Purpose of the Study:

• To compare hysterectomy (with or without oophorectomy) versus medical management.
• To evaluate effects on life expectancy, quality of life, and medical costs.
• To identify patient subgroups benefiting or losing from hysterectomy.

Main Methods:

• Decision analysis techniques were employed.
• Data on sequelae and operative mortality were utilized.
• Sensitivity analyses were performed to determine risk thresholds.

Main Results:

• Women aged 30-60 undergoing hysterectomy for specific benign conditions showed gains in life expectancy and quality of life, primarily due to cancer prevention.
• High operative risk or low expected cancer risk can lead to net losses in life expectancy.
• Younger women (<35) without estrogen replacement after hysterectomy and oophorectomy face reduced life expectancy due to increased cardiovascular and osteoporosis risks.
• Sterilization is a significant quality of life consideration for women desiring future fertility.

Conclusions:

• Hysterectomy can be beneficial for women aged 30-60 with specific gynecological conditions, balancing surgical risks against cancer prevention.
• Careful patient selection is crucial, considering individual risk factors and long-term health implications.
• Hormone replacement therapy is essential for younger women undergoing oophorectomy to mitigate long-term health risks.